ProQR Therapeutics N.V (NASDAQ: PRQR) open the trading on Thursday, with a bit cautious approach as it glided -1.15% to $3.45, before settling in for the price of $3.49 at the close. Taking a more long-term approach, PRQR posted a 52-week range of $1.11-$4.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 44.49%. Meanwhile, its Annual Earning per share during the time was 21.74%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 3.21%. This publicly-traded company’s shares outstanding now amounts to $78.46 million, simultaneously with a float of $52.75 million. The organization now has a market capitalization sitting at $281.80 million. At the time of writing, stock’s 50-day Moving Average stood at $2.19, while the 200-day Moving Average is $2.04.
ProQR Therapeutics N.V (PRQR) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. ProQR Therapeutics N.V’s current insider ownership accounts for 35.41%, in contrast to 22.17% institutional ownership.
ProQR Therapeutics N.V (PRQR) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
ProQR Therapeutics N.V’s EPS increase for this current 12-month fiscal period is 3.21% and is forecasted to reach -0.50 in the upcoming year.
ProQR Therapeutics N.V (NASDAQ: PRQR) Trading Performance Indicators
Let’s observe the current performance indicators for ProQR Therapeutics N.V (PRQR). It’s Quick Ratio in the last reported quarter now stands at 2.73. The Stock has managed to achieve an average true range (ATR) of 0.38. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.93.
In the same vein, PRQR’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.29, a figure that is expected to reach -0.11 in the next quarter, and analysts are predicting that it will be -0.50 at the market close of one year from today.
Technical Analysis of ProQR Therapeutics N.V (PRQR)
[ProQR Therapeutics N.V, PRQR] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 63.27% While, its Average True Range was 0.46.
Raw Stochastic average of ProQR Therapeutics N.V (PRQR) in the period of the previous 100 days is set at 61.13%, which indicates a major rise in contrast to 58.95% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 339.83% that was higher than 138.54% volatility it exhibited in the past 100-days period.
